<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03141645</url>
  </required_header>
  <id_info>
    <org_study_id>SIRB007</org_study_id>
    <nct_id>NCT03141645</nct_id>
  </id_info>
  <brief_title>Comparison of IV Fluid Loading and Ondansetron in Reduction of PONV After LC</brief_title>
  <official_title>Comparison of Preoperative Intravenous Fluid Loading and Ondansetron in Reduction of Incidence Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy: A Prospective Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Siriraj Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Buddhachinaraj Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Siriraj Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to examine the incidence of postoperative nausea and vomiting during
      24 hours after elective laparoscopic cholecystectomy in patients receiving preoperative
      intravenous fluid loading (group F), ondansetron (group O) and receiving neither fluid nor
      ondansetron or control group (group C).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a prospective randomized control trial. It is designed to examine the incidence
      of postoperative nausea and vomiting during 24 hours after elective laparoscopic
      cholecystectomy in patients receiving preoperative intravenous fluid loading (group F),
      ondansetron (group O) and receiving neither fluid nor ondansetron or control group (group C).
      This study is hypothesized that the incidence of PONV in patients receiving preoperative
      intravenous fluid loading (group F) and patients receiving ondansetron (group O) will be
      similarly reduced from the control group (receiving neither fluid nor ondansetron).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 20, 2017</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The incidence of postoperative nausea and vomiting</measure>
    <time_frame>24 hours</time_frame>
    <description>The incidence of postoperative nausea and vomiting within postoperative 24 hours</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">153</enrollment>
  <condition>Postoperative Nausea</condition>
  <condition>Postoperative Vomiting</condition>
  <condition>Postoperative Nausea and Vomiting</condition>
  <arm_group>
    <arm_group_label>Fluid loading group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive ringer lactate solution 10ml/kg in 15 minutes before starting operation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ondansetron group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive an 8 mg of intravenous ondansetron in 15 minutes before finishing operation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients will receive neither preoperative intravenous fluid loading nor intravenous ondansetron.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fluid loading</intervention_name>
    <description>Patients in the preoperative intravenous fluid loading group (group F) will receive ringer lactate solution 10ml/kg in 15 minutes before starting operation.</description>
    <arm_group_label>Fluid loading group</arm_group_label>
    <other_name>Preoperative IV loading</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ondansetron</intervention_name>
    <description>Patients in the ondansetron group (group O) will receive an 8 mg of intravenous ondansetron in 15 minutes before finishing operation</description>
    <arm_group_label>Ondansetron group</arm_group_label>
    <other_name>Zetron</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with aged 18 to 70 years with an ASA physical status 1-3

        Exclusion Criteria including patients

          -  with pregnant or breast-feeding patients

          -  having history of taking antiemetic drugs within 24 hours before surgery

          -  with hypersensitivity or allergy to ondansetron

          -  with CKD stage 4, 5

          -  with congestive heart failure, LVEF &lt;40

          -  with cirrhosis child c

          -  refusal or cannot communicate or understand the purpose of this study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mingkwan Wongyingsinn, MD, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty of Medicine Siririaj Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mingkwan Wongyingsinn, MD, MSc</last_name>
    <phone>+6624197990</phone>
    <phone_ext>111</phone_ext>
    <email>minkcheerful@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Mingkwan Wongyingsinn</name>
      <address>
        <city>Bangkok</city>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mingkwan Wongyingsinn, MD, MSc</last_name>
      <phone>+6624197990</phone>
      <phone_ext>111</phone_ext>
      <email>minkcheerful@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 3, 2017</study_first_submitted>
  <study_first_submitted_qc>May 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 5, 2017</study_first_posted>
  <last_update_submitted>September 14, 2017</last_update_submitted>
  <last_update_submitted_qc>September 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Siriraj Hospital</investigator_affiliation>
    <investigator_full_name>Mingkwan Wongyingsinn, MD</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nausea</mesh_term>
    <mesh_term>Vomiting</mesh_term>
    <mesh_term>Postoperative Nausea and Vomiting</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ondansetron</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

